Learn more about our Q3 2025 results

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Interim Report Q3 2025

Sales margin growth and improved adjusted EBITDA

Download report Download presentation Watch webcast recording

Pareto Securities' Healthcare Conference

Oriola attended Pareto Securities' Healthcare Conference in Stockholm on 16 September 2025 with CEO Katarina Gabrielson as a speaker.

Presentation material

Oriola's science-based climate targets

Oriola’s ambitious science-based climate targets approved by the SBTi. This approval makes Oriola one of the companies globally recognised by the SBTi as having an approved science-based net-zero target under the SBTi Net-Zero Standard.